Managing Global Supply Chain Disruptions

Learn how McKesson is responding to supply chain challenges.

By McKesson Health Systems Editorial Team

Date

December 15, 2021

By: McKesson Medical-Surgical Editorial Team

Read time: 1 minute

Headlines regarding global supply chain disruptions have flooded the news everywhere. The impact on the healthcare sector, specifically, has been devastating. but McKesson is taking a multipronged approach to address the needs of our customers and minimize the impact, including:

Internalized logistics
Greater visibility
Diversification and domestic production
Enhanced data and analytics

We’re working across the supply chain and doing our part to help deliver supplies to the point of care.

Learn how we’re addressing the delays of the current crisis and preparing for future disruptions.

Laptop beside a stack of tabbed documents on a desk with a blurred office background.

Top Prescribed Perspectives Reads of September

The top three Prescribed Perspectives articles most read by health systems in September 2026.

McKesson Wins Vizient’s 2026 Distribution Excellence Award

Vizient's 2026 Distribution Excellence Award honors suppliers that consistently deliver exceptional service and value to Vizient member health systems.

Audience members seated at an event applaud during a presentation, with several attendees visible in a conference setting.

Upcoming Event: THMA Fall Pharmacy Growth Collaborative 2026

Advancing the business of pharmacy through collaboration and shared insights

Four business attendees walk through a modern office lobby carrying work bags and luggage, with glass walls and seating in the background.

Upcoming Event: HOSP 2026 Annual Meeting

Connect with McKesson at HOSP to help advance the future of specialty pharmacy

Pharmacist standing behind a pharmacy counter, reviewing paperwork beside a computer and medication shelves.

Keeping Care Connected: Closing Visibility Gaps in Specialty Pharmacy

Brittany Ulrich, PharmD, CSP, BCBBS, examines how limited distribution drugs and payer requirements push specialty prescriptions outside the organization, eroding visibility into patient outcomes, and how Biologics by McKesson helps health systems expect more when it comes to maintaining care continuity.

Aerial view of a large warehouse complex with loading docks, trucks and intersecting roads.

Case Study: How McKesson’s Winter-Storm Playbook Kept Specialty Drugs Moving

Expect more for the business of pharmacy with a pressure-tested, multi-layered business continuity strategy.

Researcher in a laboratory looks through shelving lined with containers and supplies.

What You Should Know About the CMS Proposed 340B Payment Change

Dr. Andrew Wilson, B.S., Pharm.D., FASHP, reflects on the proposed CY 2027 OPPS rule for several outpatient drugs purchased through the 340B program, and the next phase of specialty drug margin management for the business of pharmacy.

Open laptop beside a stack of tabbed documents in a binder on a desk, with a softly blurred office background.

Top Prescribed Perspectives Reads for August

The top three Prescribed Perspectives articles most read by health systems in August.

Business professionals greet with a handshake in a modern office while colleagues stand nearby during a networking conversation.

Upcoming Event: inSPire 2026

Connect with McKesson at inSPire to help shape the future of specialty pharmacy

Healthcare professional and colleague review information on a tablet in a clinical setting.

Where Does Your Health System Fall on the Specialty and Infusion Growth Journey?

With our assessment, benchmark your progress across the specialty and infusion journey to achieve more for the business of pharmacy.

Managing Global Supply Chain Disruptions

Related Stories

Related Tags